1 Market Overview

1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain

1.2 Classification of Drugs for Osteoarthritis Pain by Type

1.2.1 Overview: Global Drugs for Osteoarthritis Pain Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2021

1.2.3 Oral

1.2.4 Injection

1.2.5 External

1.3 Global Drugs for Osteoarthritis Pain Market by Application

1.3.1 Overview: Global Drugs for Osteoarthritis Pain Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Medical Care

1.3.3 Personal Care

1.4 Global Drugs for Osteoarthritis Pain Market Size & Forecast

1.5 Global Drugs for Osteoarthritis Pain Market Size and Forecast by Region

1.5.1 Global Drugs for Osteoarthritis Pain Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Drugs for Osteoarthritis Pain Market Size by Region, (2017-2022)

1.5.3 North America Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)

1.5.4 Europe Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)

1.5.6 South America Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Drugs for Osteoarthritis Pain Market Drivers

1.6.2 Drugs for Osteoarthritis Pain Market Restraints

1.6.3 Drugs for Osteoarthritis Pain Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Drugs for Osteoarthritis Pain Product and Solutions

2.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Johnson & Johnson

2.2.1 Johnson & Johnson Details

2.2.2 Johnson & Johnson Major Business

2.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Product and Solutions

2.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Johnson & Johnson Recent Developments and Future Plans

2.3 GlaxoSmithKline

2.3.1 GlaxoSmithKline Details

2.3.2 GlaxoSmithKline Major Business

2.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Product and Solutions

2.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 GlaxoSmithKline Recent Developments and Future Plans

2.4 Bayer

2.4.1 Bayer Details

2.4.2 Bayer Major Business

2.4.3 Bayer Drugs for Osteoarthritis Pain Product and Solutions

2.4.4 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Bayer Recent Developments and Future Plans

2.5 Eli Lilly

2.5.1 Eli Lilly Details

2.5.2 Eli Lilly Major Business

2.5.3 Eli Lilly Drugs for Osteoarthritis Pain Product and Solutions

2.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Eli Lilly Recent Developments and Future Plans

2.6 Novartis

2.6.1 Novartis Details

2.6.2 Novartis Major Business

2.6.3 Novartis Drugs for Osteoarthritis Pain Product and Solutions

2.6.4 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Novartis Recent Developments and Future Plans

2.7 Sanofi

2.7.1 Sanofi Details

2.7.2 Sanofi Major Business

2.7.3 Sanofi Drugs for Osteoarthritis Pain Product and Solutions

2.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Sanofi Recent Developments and Future Plans

2.8 Horizon Pharma

2.8.1 Horizon Pharma Details

2.8.2 Horizon Pharma Major Business

2.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Product and Solutions

2.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Horizon Pharma Recent Developments and Future Plans

2.9 Abbott

2.9.1 Abbott Details

2.9.2 Abbott Major Business

2.9.3 Abbott Drugs for Osteoarthritis Pain Product and Solutions

2.9.4 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Abbott Recent Developments and Future Plans

2.10 Mylan

2.10.1 Mylan Details

2.10.2 Mylan Major Business

2.10.3 Mylan Drugs for Osteoarthritis Pain Product and Solutions

2.10.4 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Mylan Recent Developments and Future Plans

2.11 Daiichi Sankyo

2.11.1 Daiichi Sankyo Details

2.11.2 Daiichi Sankyo Major Business

2.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Product and Solutions

2.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Daiichi Sankyo Recent Developments and Future Plans

2.12 TEVA

2.12.1 TEVA Details

2.12.2 TEVA Major Business

2.12.3 TEVA Drugs for Osteoarthritis Pain Product and Solutions

2.12.4 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 TEVA Recent Developments and Future Plans

2.13 Almatica Pharma

2.13.1 Almatica Pharma Details

2.13.2 Almatica Pharma Major Business

2.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Product and Solutions

2.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Almatica Pharma Recent Developments and Future Plans

2.14 Astellas Pharma

2.14.1 Astellas Pharma Details

2.14.2 Astellas Pharma Major Business

2.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Product and Solutions

2.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Astellas Pharma Recent Developments and Future Plans

2.15 Tide Pharmaceutical

2.15.1 Tide Pharmaceutical Details

2.15.2 Tide Pharmaceutical Major Business

2.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions

2.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Tide Pharmaceutical Recent Developments and Future Plans

2.16 Iroko Pharmaceuticals

2.16.1 Iroko Pharmaceuticals Details

2.16.2 Iroko Pharmaceuticals Major Business

2.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product and Solutions

2.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Iroko Pharmaceuticals Recent Developments and Future Plans

2.17 Hengrui Pharmaceutical

2.17.1 Hengrui Pharmaceutical Details

2.17.2 Hengrui Pharmaceutical Major Business

2.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions

2.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Hengrui Pharmaceutical Recent Developments and Future Plans

2.18 Abiogen Pharma

2.18.1 Abiogen Pharma Details

2.18.2 Abiogen Pharma Major Business

2.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Product and Solutions

2.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Abiogen Pharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Drugs for Osteoarthritis Pain Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Drugs for Osteoarthritis Pain Players Market Share in 2021

3.2.2 Top 10 Drugs for Osteoarthritis Pain Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Drugs for Osteoarthritis Pain Players Head Office, Products and Services Provided

3.4 Drugs for Osteoarthritis Pain Mergers & Acquisitions

3.5 Drugs for Osteoarthritis Pain New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2017-2022)

4.2 Global Drugs for Osteoarthritis Pain Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2017-2022)

5.2 Global Drugs for Osteoarthritis Pain Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)

6.2 North America Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)

6.3 North America Drugs for Osteoarthritis Pain Market Size by Country

6.3.1 North America Drugs for Osteoarthritis Pain Revenue by Country (2017-2028)

6.3.2 United States Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

6.3.3 Canada Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

6.3.4 Mexico Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)

7.2 Europe Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)

7.3 Europe Drugs for Osteoarthritis Pain Market Size by Country

7.3.1 Europe Drugs for Osteoarthritis Pain Revenue by Country (2017-2028)

7.3.2 Germany Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

7.3.3 France Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

7.3.5 Russia Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

7.3.6 Italy Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)

8.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)

8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region

8.3.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2017-2028)

8.3.2 China Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

8.3.3 Japan Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

8.3.4 South Korea Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

8.3.5 India Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

8.3.7 Australia Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)

9.2 South America Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)

9.3 South America Drugs for Osteoarthritis Pain Market Size by Country

9.3.1 South America Drugs for Osteoarthritis Pain Revenue by Country (2017-2028)

9.3.2 Brazil Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

9.3.3 Argentina Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)

10.2 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)

10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country

10.3.1 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Country (2017-2028)

10.3.2 Turkey Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

10.3.4 UAE Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Drugs for Osteoarthritis Pain Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Drugs for Osteoarthritis Pain Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Drugs for Osteoarthritis Pain Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Drugs for Osteoarthritis Pain Revenue (USD Million) by Region (2017-2022)

Table 5. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Drugs for Osteoarthritis Pain Product and Solutions

Table 9. Pfizer Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 11. Johnson & Johnson Major Business

Table 12. Johnson & Johnson Drugs for Osteoarthritis Pain Product and Solutions

Table 13. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 15. GlaxoSmithKline Major Business

Table 16. GlaxoSmithKline Drugs for Osteoarthritis Pain Product and Solutions

Table 17. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Bayer Corporate Information, Head Office, and Major Competitors

Table 19. Bayer Major Business

Table 20. Bayer Drugs for Osteoarthritis Pain Product and Solutions

Table 21. Bayer Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 23. Eli Lilly Major Business

Table 24. Eli Lilly Drugs for Osteoarthritis Pain Product and Solutions

Table 25. Eli Lilly Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Novartis Corporate Information, Head Office, and Major Competitors

Table 27. Novartis Major Business

Table 28. Novartis Drugs for Osteoarthritis Pain Product and Solutions

Table 29. Novartis Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Sanofi Corporate Information, Head Office, and Major Competitors

Table 31. Sanofi Major Business

Table 32. Sanofi Drugs for Osteoarthritis Pain Product and Solutions

Table 33. Sanofi Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Horizon Pharma Corporate Information, Head Office, and Major Competitors

Table 35. Horizon Pharma Major Business

Table 36. Horizon Pharma Drugs for Osteoarthritis Pain Product and Solutions

Table 37. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Abbott Corporate Information, Head Office, and Major Competitors

Table 39. Abbott Major Business

Table 40. Abbott Drugs for Osteoarthritis Pain Product and Solutions

Table 41. Abbott Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Mylan Corporate Information, Head Office, and Major Competitors

Table 43. Mylan Major Business

Table 44. Mylan Drugs for Osteoarthritis Pain Product and Solutions

Table 45. Mylan Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors

Table 47. Daiichi Sankyo Major Business

Table 48. Daiichi Sankyo Drugs for Osteoarthritis Pain Product and Solutions

Table 49. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. TEVA Corporate Information, Head Office, and Major Competitors

Table 51. TEVA Major Business

Table 52. TEVA Drugs for Osteoarthritis Pain Product and Solutions

Table 53. TEVA Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Almatica Pharma Corporate Information, Head Office, and Major Competitors

Table 55. Almatica Pharma Major Business

Table 56. Almatica Pharma Drugs for Osteoarthritis Pain Product and Solutions

Table 57. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 59. Astellas Pharma Major Business

Table 60. Astellas Pharma Drugs for Osteoarthritis Pain Product and Solutions

Table 61. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Tide Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 63. Tide Pharmaceutical Major Business

Table 64. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions

Table 65. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Iroko Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 67. Iroko Pharmaceuticals Major Business

Table 68. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product and Solutions

Table 69. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Hengrui Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 71. Hengrui Pharmaceutical Major Business

Table 72. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions

Table 73. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Abiogen Pharma Corporate Information, Head Office, and Major Competitors

Table 75. Abiogen Pharma Major Business

Table 76. Abiogen Pharma Drugs for Osteoarthritis Pain Product and Solutions

Table 77. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Global Drugs for Osteoarthritis Pain Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 79. Global Drugs for Osteoarthritis Pain Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 80. Breakdown of Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2 and Tier 3)

Table 81. Drugs for Osteoarthritis Pain Players Head Office, Products and Services Provided

Table 82. Drugs for Osteoarthritis Pain Mergers & Acquisitions in the Past Five Years

Table 83. Drugs for Osteoarthritis Pain New Entrants and Expansion Plans

Table 84. Global Drugs for Osteoarthritis Pain Revenue (USD Million) by Type (2017-2022)

Table 85. Global Drugs for Osteoarthritis Pain Revenue Share by Type (2017-2022)

Table 86. Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2023-2028)

Table 87. Global Drugs for Osteoarthritis Pain Revenue by Application (2017-2022)

Table 88. Global Drugs for Osteoarthritis Pain Revenue Forecast by Application (2023-2028)

Table 89. North America Drugs for Osteoarthritis Pain Revenue by Type (2017-2022) & (USD Million)

Table 90. North America Drugs for Osteoarthritis Pain Revenue by Type (2023-2028) & (USD Million)

Table 91. North America Drugs for Osteoarthritis Pain Revenue by Application (2017-2022) & (USD Million)

Table 92. North America Drugs for Osteoarthritis Pain Revenue by Application (2023-2028) & (USD Million)

Table 93. North America Drugs for Osteoarthritis Pain Revenue by Country (2017-2022) & (USD Million)

Table 94. North America Drugs for Osteoarthritis Pain Revenue by Country (2023-2028) & (USD Million)

Table 95. Europe Drugs for Osteoarthritis Pain Revenue by Type (2017-2022) & (USD Million)

Table 96. Europe Drugs for Osteoarthritis Pain Revenue by Type (2023-2028) & (USD Million)

Table 97. Europe Drugs for Osteoarthritis Pain Revenue by Application (2017-2022) & (USD Million)

Table 98. Europe Drugs for Osteoarthritis Pain Revenue by Application (2023-2028) & (USD Million)

Table 99. Europe Drugs for Osteoarthritis Pain Revenue by Country (2017-2022) & (USD Million)

Table 100. Europe Drugs for Osteoarthritis Pain Revenue by Country (2023-2028) & (USD Million)

Table 101. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2017-2022) & (USD Million)

Table 102. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2023-2028) & (USD Million)

Table 103. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2017-2022) & (USD Million)

Table 104. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2023-2028) & (USD Million)

Table 105. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2017-2022) & (USD Million)

Table 106. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2023-2028) & (USD Million)

Table 107. South America Drugs for Osteoarthritis Pain Revenue by Type (2017-2022) & (USD Million)

Table 108. South America Drugs for Osteoarthritis Pain Revenue by Type (2023-2028) & (USD Million)

Table 109. South America Drugs for Osteoarthritis Pain Revenue by Application (2017-2022) & (USD Million)

Table 110. South America Drugs for Osteoarthritis Pain Revenue by Application (2023-2028) & (USD Million)

Table 111. South America Drugs for Osteoarthritis Pain Revenue by Country (2017-2022) & (USD Million)

Table 112. South America Drugs for Osteoarthritis Pain Revenue by Country (2023-2028) & (USD Million)

Table 113. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Type (2017-2022) & (USD Million)

Table 114. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Type (2023-2028) & (USD Million)

Table 115. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Application (2017-2022) & (USD Million)

Table 116. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Application (2023-2028) & (USD Million)

Table 117. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Country (2017-2022) & (USD Million)

Table 118. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Drugs for Osteoarthritis Pain Picture

Figure 2. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2021

Figure 3. Oral

Figure 4. Injection

Figure 5. External

Figure 6. Drugs for Osteoarthritis Pain Revenue Market Share by Application in 2021

Figure 7. Medical Care Picture

Figure 8. Personal Care Picture

Figure 9. Global Drugs for Osteoarthritis Pain Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Drugs for Osteoarthritis Pain Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2017-2028)

Figure 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region in 2021

Figure 13. North America Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Drugs for Osteoarthritis Pain Market Drivers

Figure 19. Drugs for Osteoarthritis Pain Market Restraints

Figure 20. Drugs for Osteoarthritis Pain Market Trends

Figure 21. Pfizer Recent Developments and Future Plans

Figure 22. Johnson & Johnson Recent Developments and Future Plans

Figure 23. GlaxoSmithKline Recent Developments and Future Plans

Figure 24. Bayer Recent Developments and Future Plans

Figure 25. Eli Lilly Recent Developments and Future Plans

Figure 26. Novartis Recent Developments and Future Plans

Figure 27. Sanofi Recent Developments and Future Plans

Figure 28. Horizon Pharma Recent Developments and Future Plans

Figure 29. Abbott Recent Developments and Future Plans

Figure 30. Mylan Recent Developments and Future Plans

Figure 31. Daiichi Sankyo Recent Developments and Future Plans

Figure 32. TEVA Recent Developments and Future Plans

Figure 33. Almatica Pharma Recent Developments and Future Plans

Figure 34. Astellas Pharma Recent Developments and Future Plans

Figure 35. Tide Pharmaceutical Recent Developments and Future Plans

Figure 36. Iroko Pharmaceuticals Recent Developments and Future Plans

Figure 37. Hengrui Pharmaceutical Recent Developments and Future Plans

Figure 38. Abiogen Pharma Recent Developments and Future Plans

Figure 39. Global Drugs for Osteoarthritis Pain Revenue Share by Players in 2021

Figure 40. Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 41. Global Top 3 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2021

Figure 42. Global Top 10 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2021

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 44. Global Drugs for Osteoarthritis Pain Revenue Share by Type in 2021

Figure 45. Global Drugs for Osteoarthritis Pain Market Share Forecast by Type (2023-2028)

Figure 46. Global Drugs for Osteoarthritis Pain Revenue Share by Application in 2021

Figure 47. Global Drugs for Osteoarthritis Pain Market Share Forecast by Application (2023-2028)

Figure 48. North America Drugs for Osteoarthritis Pain Sales Market Share by Type (2017-2028)

Figure 49. North America Drugs for Osteoarthritis Pain Sales Market Share by Application (2017-2028)

Figure 50. North America Drugs for Osteoarthritis Pain Revenue Market Share by Country (2017-2028)

Figure 51. United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Europe Drugs for Osteoarthritis Pain Sales Market Share by Type (2017-2028)

Figure 55. Europe Drugs for Osteoarthritis Pain Sales Market Share by Application (2017-2028)

Figure 56. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Country (2017-2028)

Figure 57. Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. United Kingdom Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share by Type (2017-2028)

Figure 63. Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share by Application (2017-2028)

Figure 64. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Region (2017-2028)

Figure 65. China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Australia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. South America Drugs for Osteoarthritis Pain Sales Market Share by Type (2017-2028)

Figure 72. South America Drugs for Osteoarthritis Pain Sales Market Share by Application (2017-2028)

Figure 73. South America Drugs for Osteoarthritis Pain Revenue Market Share by Country (2017-2028)

Figure 74. Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Middle East and Africa Drugs for Osteoarthritis Pain Sales Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Drugs for Osteoarthritis Pain Sales Market Share by Application (2017-2028)

Figure 78. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Country (2017-2028)

Figure 79. Turkey Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source